Progress in Immunotherapy and Precision Medicine: Key Insights from JTCC at ASH 2024 - Episode 1
Andre Goy, MD, discusses how progress in immunotherapy and precision medicine at ASH 2024 is shaping the future of cancer treatment, with key insights from the JTCC highlighting emerging therapies and their potential to improve patient outcomes through personalized approaches.